Foods high in soluble and fermentable fiber, such as legumes, oats, barley, berries, brussels sprouts, and leafy greens, can be gradually incorporated into daily meals to promote the production of short-chain fatty acids in the gut, which in turn stimulates GLP-1 secretion
This study aims to explore the link between endothelial dysfunction, a key component of HFpEF, and the therapeutic actions of GLP-1RAs
For those who discontinue GLP-1s, implementing comprehensive lifestyle changes becomes crucial
B12 injections contain only cyanocobalamin or methylcobalamin and address B12 deficiency or support folate-dependent methylation pathways
Under research conditions, activation of GLP-1 and GIP receptors has been linked to modulation of glucose-dependent insulinotropic responses, regulation of glucagon secretion and effects on incretin signalling related to control of energy intake
Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)
